Efficacy of Repetitive Peripheral Magnetic Stimulation in reduction of spasticity in neurology patients

Efficacy of Repetitive Peripheral Magnetic Stimulation in reduction of limb spasticity in neurology patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202009622405087

Enrollment

Registered

2020-09-14

Start date

2020-03-01

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases

Interventions

repetitive peripheral magnetic stimulation

sham peripheral magnetic stimulation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age between 18-65 yrs. Disease duration >6 months Spasticity on modified Ashworth scale = 1+ that has been present over the past month.

Exclusion criteria

Exclusion criteria: Recent (<4 months) botulinum toxin injection A metal plate along the spastic limbs Patients with pacemakers Pregnant females.

Design outcomes

Primary

Measure	Time frame
Reduction of spasticity by a change in modified Ashworth scale (mAS)	—

Secondary

Measure	Time frame
Reduction of estimated dose of Onabotulinum toxin A (eBTD).;in a group of patients , assessment of the the function with Fugel Meyer scale will be done	—

Countries

Egypt

Contacts

Public ContactFatma Kenawy

Lecturer of Neurology

fatma.fathalla@gmai.com00201128593444

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Jun 27, 2026